Navigation Links
Pycnogenol (French maritime pine bark extract) shown to improve menopause symptoms in new study
Date:3/7/2012

(March 7, 2012) HOBOKEN, NJ Half the population experiences menopause, and for those women, it is a condition they will experience for approximately one third of their lifetime. Alternative or natural remedies are an easy, effective way to improve signs and symptoms linked to the menopausal transition, without side effects. Natural supplement Pycnogenol (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, was found to significantly improve signs and symptoms of menopause in a recent clinical trial published in Panminerva Medica.

The study was conducted at Pescara University and examined 70 perimenopausal women, aged 40-50 years. Perimenopause is the term used to describe the menopause transition years, typically the years before and after the final menstrual period. Participants were assigned to a placebo or test group. The test group was given 100 mg of Pycnogenol per day (50 mg taken twice daily), over a period of eight weeks. Participants' menopausal symptoms were evaluated by a scoring system, based on a total of 33 common signs and symptoms, using values ranging from zero (absent) to a maximum of four (very serious). Oxidative stress levels were evaluated by measuring capillary blood plasma free radicals from a drop of capillary blood from the finger tips.

The study found that:

  • Pycnogenol substantially improved perimenopausal signs and symptoms including hot flashes, night sweats, mood swings, irregular periods, loss of libido and vaginal dryness after eight weeks of treatment, as judged by patients' scores, showing a decrease from an average of 2.67/4 to 1.45/4
  • Pycnogenol effectively decreased the severity of hot flashes, decreased bloating and improved irregular heart beat and improved digestive problems
  • Menopausal symptoms categorized under "pain" improved significantly with the group taking Pycnogenol
  • Oxidative stress levels decreased significantly after Pycnogenol supplementation, improving quality of life and helping to control signs and symptoms of menopause

"As evidenced by this study, Pycnogenol may arguably represent a very effective basic, daily dietary supplement for menopausal women due to its extended range of health benefits, including cardiovascular benefits and Pycnogenol's proven ability to lower blood pressure," says Dr. Gianni Belcaro, the lead researcher from Pescara University, Italy.

Results showed that not only did Pycnogenol improve menopausal signs and symptoms, but also decreased elevated levels of oxidative stress, as shown by capillary blood tests. Pycnogenol's ability to manage heart health is of particular significance as menopausal women live at elevated risk for cardiovascular disease.

This study confirms previous findings that Pycnogenol effectively improves perimenopausal signs and symptoms. A previous study in Taiwan investigated 200 mg of Pycnogenol in 200 perimenopausal women over a period of half a year and identified an improvement in most signs and symptoms. This study demonstrated Pycnogenol's ability to improve signs and symptoms not only with a smaller dosage of Pycnogenol but also over a shorter period of time.


'/>"/>

Contact: Katherine Davis
kdavis@mww.com
312-981-8549
MWW Group
Source:Eurekalert

Related biology news :

1. Pycnogenol (French maritime pine bark extract) shown to improve visible signs of aging in new study
2. Growing Demand for Rapid Screening and Detection Systems Pushes the European Maritime Security Market, Finds Frost & Sullivan
3. ComCam Selected by ePortation on New Maritime Domain Awareness Project
4. ComCam Selected by ePortation on New Maritime Domain Awareness Project
5. Stevens and TNO to collaborate on maritime security
6. National Center for Secure and Resilient Maritime Commerce releases annual report
7. New ways to chart our maritime past
8. NOAA, Spain announce cooperative arrangement to preserve maritime underwater heritage
9. Ultrasound shown to exert remote control of brain circuits
10. Dictyostelium cells shown to lay breadcrumb trail as first step in multicellular formation
11. Twin nanoparticle shown effective at targeting, killing breast cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the medical ... premium product recently added to the range of products distributed by Ampronix. ... ... ... Ampronix News ...
(Date:5/9/2016)... , UAE, May 9, 2016 ... when it comes to expanding freedom for high net ... Even in today,s globally connected world, there is ... conferencing system could ever duplicate sealing your deal with ... obtaining second passports by taking advantage of citizenship via ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer experts from Austria, ... could be a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma ... read it now. , Biomarkers are components in the blood, tissue or ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology: